Bioceres Crop Solutions (BIOX) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $0.29, -2.00% vs the prior close of $0.30.
- Volume 251.20K shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
BIOX dips 2.0% to $0.29, a 52-week low, 3 down days in a row. Closed at $0.29, -2.00% vs the prior close of $0.30. Day range $0.28–$0.32, opened at $0.30.
BIOX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — BIOX dips 2.0% to $0.29, a 52-week low, 3 down days in a row
- Closed at $0.29, -2.00% vs the prior close of $0.30. Day range $0.28–$0.32, opened at $0.30.
- Volume was 251.20K shares, 0.8x its 50-day average of 329.87K.
- Price is -23.7% vs its 50-day average ($0.39) and -44.5% vs its 200-day average ($0.53).
- 52-week range $0.28–$2.19; today's close sits at 1% of that range, 86.6% below the 52-week high.
- That makes 3 straight losses.
Oct 14, 2026 — BIOX slides 7.7% to $0.30, a 52-week low
- Closed at $0.30, -7.69% vs the prior close of $0.32. Day range $0.30–$0.33, opened at $0.32.
- Volume was 239.80K shares, 0.7x its 50-day average of 326.01K.
- Price is -22.4% vs its 50-day average ($0.39) and -43.9% vs its 200-day average ($0.53).
- 52-week range $0.30–$2.19; today's close sits at 0% of that range, 86.3% below the 52-week high.
Oct 13, 2026 — BIOX dips 1.8% to $0.32, a 1-month low
- Closed at $0.32, -1.81% vs the prior close of $0.33. Day range $0.32–$0.34, opened at $0.33.
- Volume was 31.20K shares, 0.1x its 50-day average of 329.09K — lighter than usual.
- Price is -16.3% vs its 50-day average ($0.39) and -39.8% vs its 200-day average ($0.54).
- 52-week range $0.30–$2.19; today's close sits at 1% of that range, 85.2% below the 52-week high.
Oct 12, 2026 — BIOX rises 0.9% to $0.33
- Closed at $0.33, +0.91% vs the prior close of $0.33. Day range $0.32–$0.34, opened at $0.33.
- Volume was 110.10K shares, 0.3x its 50-day average of 328.23K — lighter than usual.
- Price is -14.9% vs its 50-day average ($0.39) and -39.2% vs its 200-day average ($0.54).
- 52-week range $0.30–$2.19; today's close sits at 2% of that range, 84.9% below the 52-week high.
Oct 9, 2026 — BIOX ends flat (+0.0%) to $0.33, 4 down days in a row
- Closed at $0.33, +0.00% vs the prior close of $0.33. Day range $0.32–$0.34, opened at $0.33.
- Volume was 127.30K shares, 0.4x its 50-day average of 326.85K — lighter than usual.
- Price is -15.8% vs its 50-day average ($0.39) and -40.4% vs its 200-day average ($0.55).
- 52-week range $0.30–$2.19; today's close sits at 1% of that range, 85.0% below the 52-week high.
- That makes 4 straight losses.
Oct 8, 2026 — BIOX dips 2.1% to $0.33, a 1-month low, 3 down days in a row
- Closed at $0.33, -2.09% vs the prior close of $0.34. Day range $0.32–$0.34, opened at $0.32.
- Volume was 55.10K shares, 0.2x its 50-day average of 327.33K — lighter than usual.
- Price is -15.8% vs its 50-day average ($0.39) and -40.9% vs its 200-day average ($0.55).
- 52-week range $0.30–$2.19; today's close sits at 1% of that range, 85.0% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — BIOX dips 1.5% to $0.34, a 1-month low
- Closed at $0.34, -1.47% vs the prior close of $0.34. Day range $0.32–$0.35, opened at $0.34.
- Volume was 131.30K shares, 0.4x its 50-day average of 325.88K — lighter than usual.
- Price is -14.0% vs its 50-day average ($0.39) and -40.2% vs its 200-day average ($0.56).
- 52-week range $0.30–$2.19; today's close sits at 2% of that range, 84.7% below the 52-week high.
Oct 6, 2026 — BIOX dips 1.7% to $0.34, a 1-month low
- Closed at $0.34, -1.73% vs the prior close of $0.35. Day range $0.33–$0.35, opened at $0.33.
- Volume was 93.10K shares, 0.3x its 50-day average of 325.76K — lighter than usual.
- Price is -12.7% vs its 50-day average ($0.39) and -39.9% vs its 200-day average ($0.57).
- 52-week range $0.30–$2.19; today's close sits at 2% of that range, 84.5% below the 52-week high.
Oct 5, 2026 — BIOX rises 1.2% to $0.35
- Closed at $0.35, +1.17% vs the prior close of $0.34. Day range $0.31–$0.36, opened at $0.34.
- Volume was 288.30K shares, 0.9x its 50-day average of 321.74K.
- Price is -11.1% vs its 50-day average ($0.39) and -39.4% vs its 200-day average ($0.57).
- 52-week range $0.30–$2.19; today's close sits at 2% of that range, 84.2% below the 52-week high.
Oct 2, 2026 — BIOX dips 2.0% to $0.34, a 1-month low
- Closed at $0.34, -2.01% vs the prior close of $0.35. Day range $0.34–$0.36, opened at $0.34.
- Volume was 73.40K shares, 0.2x its 50-day average of 326.63K — lighter than usual.
- Price is -12.1% vs its 50-day average ($0.39) and -40.7% vs its 200-day average ($0.58).
- 52-week range $0.30–$2.19; today's close sits at 2% of that range, 84.4% below the 52-week high.
BIOX latest news & SEC filings
Every SEC filing by or about BIOX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 21, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 16, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 10, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 7, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 22, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade BIOX
- How much it moves: over the last 20 sessions the average daily move was 2.36% (largest 8.9%).
- Liquidity: about 215.94K shares (≈$63.49K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.29 vs a range of $0.28–$2.19 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Sep 21, 2026; 6-K Sep 16, 2026; 6-K Jun 22, 2026.
- Listing: Nasdaq · industry: Agricultural Chemicals.
BIOX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 0.30 | 0.32 | 0.28 | 0.29 | 251.20K |
| Oct 14, 2026 | 0.32 | 0.33 | 0.30 | 0.30 | 239.80K |
| Oct 13, 2026 | 0.33 | 0.34 | 0.32 | 0.32 | 31.20K |
| Oct 12, 2026 | 0.33 | 0.34 | 0.32 | 0.33 | 110.10K |
| Oct 9, 2026 | 0.33 | 0.34 | 0.32 | 0.33 | 127.30K |
| Oct 8, 2026 | 0.32 | 0.34 | 0.32 | 0.33 | 55.10K |
| Oct 7, 2026 | 0.34 | 0.35 | 0.32 | 0.34 | 131.30K |
| Oct 6, 2026 | 0.33 | 0.35 | 0.33 | 0.34 | 93.10K |
| Oct 5, 2026 | 0.34 | 0.36 | 0.31 | 0.35 | 288.30K |
| Oct 2, 2026 | 0.34 | 0.36 | 0.34 | 0.34 | 73.40K |
| Oct 1, 2026 | 0.35 | 0.36 | 0.35 | 0.35 | 34.80K |
| Sep 30, 2026 | 0.35 | 0.36 | 0.33 | 0.35 | 56.60K |
| Sep 29, 2026 | 0.37 | 0.37 | 0.34 | 0.35 | 185.00K |
| Sep 28, 2026 | 0.36 | 0.38 | 0.35 | 0.36 | 39.00K |
| Sep 25, 2026 | 0.37 | 0.38 | 0.36 | 0.37 | 73.30K |
| Sep 24, 2026 | 0.38 | 0.39 | 0.35 | 0.37 | 239.10K |
| Sep 23, 2026 | 0.35 | 0.39 | 0.33 | 0.39 | 413.80K |
| Sep 22, 2026 | 0.36 | 0.36 | 0.32 | 0.36 | 633.90K |
| Sep 21, 2026 | 0.37 | 0.38 | 0.35 | 0.36 | 433.40K |
| Sep 18, 2026 | 0.40 | 0.40 | 0.34 | 0.36 | 809.10K |
About Bioceres Crop Solutions
Bioceres Crop Solutions (BIOX) is listed on the Nasdaq and classified by the SEC under “Agricultural Chemicals”. Its business address is in GEORGE TOWN, GRAND CAYMAN, Cayman Islands. State of incorporation: Cayman Islands. Fiscal year ends June 30. SEC CIK 1769484.
BIOX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Narain Duraiswami | Director | May 12, 2026 |
| Yogesh Mago | Director | May 11, 2026 |
| Federico Trucco | CEO | Aug 10, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jose Augusto Roque | General Counsel | Apr 22, 2026 |
| Ezequiel Simmermacher | CFO | Aug 4, 2026 |
| Federico Trucco | CEO | Aug 10, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
BIOX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
BIOX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Agricultural Chemicals
CF Industries (CF)Nutrien (NTR)Mosaic (MOS)Scotts Miracle-Gro (SMG)SenesTech (SNES)Icl (ICL)Cvr Partners (UAN)American Vanguard (AVD)Cibus (CBUS)Fort Technology (FRTT)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on BIOX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.